NCT00654433View on ClinicalTrials.gov

ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases

PHASE3TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

November 30, 2011

Conditions
Inherited Metabolic DiseasesLysosomal Storage DisordersPeroxisomal Storage DiseasesInborn Errors of MetabolismMucopolysaccharidosis
Interventions
BIOLOGICAL

ALD-101

A subpopulation of cord blood cells composed of cells that express a high level of the intracellular enzyme aldehyde dehydrogenase (ALDH).

Trial Locations (3)

27705

Mt. Sinai Medical Center, New York

Duke University, Durham

90095

Mattel Children's Hospital at UCLA, Los Angeles

Sponsors

Lead Sponsor

Aldagen
All Listed Sponsors
lead

Aldagen

INDUSTRY

NCT00654433 - ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases | Biotech Hunter | Biotech Hunter